N. Russell

J. Dixon, I. Kunkler, N. Russell, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A source document and case report form for prospective documentation of breast cancer radiotherapy parameters for use in trials or studies.

C. Hurkmans, E. van Leeuwen-Stok, N. Russell, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Lymphatic Drainage Patterns in Breast Cancer Patients Who Previously Underwent Mantle Field Radiation

E. Rutgers, H. Oldenburg, O. Nieweg, 2009, Annals of Surgical Oncology.

The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors.

D. Voskuil, C. Gundy, M. Rookus, 2009, European journal of cancer.

Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells.

F. Stewart, P. ten Dijke, J. Kruse, 2009, International journal of radiation oncology, biology, physics.

ALK1 heterozygosity delays development of late normal tissue damage in the irradiated mouse kidney.

F. Stewart, N. Russell, M. Scharpfenecker, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Anti-inflammatory and anti-thrombotic intervention strategies using atorvastatin, clopidogrel and knock-down of CD40L do not modify radiation-induced atherosclerosis in ApoE null mice.

F. Stewart, M. Daemen, S. Hoving, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Risk communication in a patient decision aid for radiotherapy in breast cancer: How to deal with uncertainty?

L. Boersma, H. D. van den Bongard, J. Maduro, 2020, Breast.

What do patients and health care professionals view as important attributes in radiotherapy decisions? Input for a breast cancer patient decision aid

L. Boersma, T. van der Weijden, N. Russell, 2019, Breast.

Optimizing MR-Guided Radiotherapy for Breast Cancer Patients

J. Lagendijk, L. Braunstein, H. Verkooijen, 2020, Frontiers in Oncology.

Irradiation induces different inflammatory and thrombotic responses in carotid arteries of wildtype C57BL/6J and atherosclerosis-prone ApoE(-/-) mice.

F. Stewart, M. Daemen, S. Hoving, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Blood and lymphatic microvessel damage in irradiated human skin: The role of TGF-β, endoglin and macrophages.

F. Stewart, E. van Werkhoven, Regina de Jong-Korlaar, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.

L. Collette, A. Dekker, M. Scorsetti, 2020, The Lancet. Oncology.

Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial.

H. Bartelink, L. Boersma, E. van Werkhoven, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure

P. Elkhuizen, C. Loo, M. Straver, 2018, Annals of Surgical Oncology.

Combined skin-sparing mastectomy and immediate implant-based breast reconstruction: Outcome following mantle field irradiation versus outcome following whole-breast irradiation.

E. Rutgers, N. Russell, L. Woerdeman, 2021, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapy.

E. Rutgers, S. Linn, J. Wesseling, 2009, American journal of surgery.

Effects of Lycopene on the Insulin-Like Growth Factor (IGF) System in Premenopausal Breast Cancer Survivors and Women at High Familial Breast Cancer Risk

L. V. van't Veer, D. Voskuil, S. Verhoef, 2008, Nutrition and cancer.

NO-Donating Aspirin and Aspirin Partially Inhibit Age-Related Atherosclerosis but Not Radiation-Induced Atherosclerosis in ApoE Null Mice

F. Stewart, M. Daemen, S. Hoving, 2010, PloS one.

Radiation-Induced Activation of TGF-β Signaling Pathways in Relation to Vascular Damage in Mouse Kidneys

F. Stewart, J. Kruse, N. Russell, 2009, Radiation research.

Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents

F. Stewart, S. Hoving, Ji-Ying Song, 2013, Breast Cancer Research and Treatment.

Quality of life at 2-year follow-up of SUPREMO randomised trial of post mastectomy radiotherapy for breast cancer Quality of life after post mastectomy radiotherapy EORTC SUPREMO trial investigators

J. Dixon, I. Kunkler, G. Velikova, 2019 .

Defective repair of DNA double-strand breaks and chromosome damage in fibroblasts from a radiosensitive leukemia patient.

R. Okayasu, A. Begg, C. Badie, 1995, Cancer research.

Adaptive phase II randomized trial of nivolumab after induction treatment in triple negative breast cancer (TONIC trial): Final response data stage I and first translational data.

H. Horlings, T. Schumacher, S. Linn, 2018 .

Why is breast cancer so frequent in The Netherlands?

P. Bruning, N. Russell, A. Ansink, 1988, European Journal of Surgical Oncology.

Breast cancer patients’ most important quality of life themes for a radiotherapy decision aid

H. Verkooijen, L. Boersma, L. Wee, 2022, Breast.

Head and neck cancer.

H. Bartelink, G. Snow, N. Russell, 1993, The New England journal of medicine.

[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].

S. Rodenhuis, E. Rutgers, S. Linn, 2008, Nederlands tijdschrift voor geneeskunde.

Consensus on contouring primary breast tumors on MRI in the setting of neoadjuvant partial breast irradiation in trials.

H. Verkooijen, L. Braunstein, H. D. van den Bongard, 2020, Practical radiation oncology.

Quality of life at 2-year follow-up of SUPREMO randomised trial of post mastectomy radiotherapy for breast cancer Short title Quality of life after post mastectomy radiotherapy

J. Dixon, I. Kunkler, G. Velikova, 2019 .

The TGF-β co-receptor endoglin regulates macrophage infiltration and cytokine production in the irradiated mouse kidney.

F. Stewart, N. Russell, M. Scharpfenecker, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Bone marrow-derived macrophages incorporate into the endothelium and influence vascular and renal function after irradiation

F. Stewart, R. Coppes, N. Russell, 2014, International journal of radiation biology.

Re: Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective.

I. Kunkler, P. Canney, N. Russell, 2006, Journal of the National Cancer Institute.

Determining the indications for post mastectomy radiotherapy: moving from 20th century clinical staging to 21st century biological criteria.

G. Tienhoven, I. Kunkler, N. Russell, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Is There an Indication for Digital Subtraction Angiography in the Assessment of Irradiation-Induced Vascular Damage before Free Flap Surgery by the Means of the Internal Mammary Vessels?

S. Hoving, P. Werker, N. Russell, 2013, Journal of Reconstructive Microsurgery.

Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial.

H. Bartelink, L. Boersma, E. van Werkhoven, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Breast Cancer Risk in Female Survivors of Hodgkin’s Lymphoma: Lower Risk After Smaller Radiation Volumes OF LINICAL NCOLOGY

A. Broeks, E. Noordijk, M. Louwman, 2009 .

Radiation as an independent risk factor for atherosclerosis

F. Stewart, M. Daemen, S. Hoving, 2008 .

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

A. Broeks, E. Noordijk, M. Stovall, 2003, Journal of the National Cancer Institute.

Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study

J. Klijn, A. Broeks, M. Schmidt, 2007, Breast Cancer Research.

Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study

M. Hauptmann, M. Hooning, A. Jager, 2020, Breast Cancer Research and Treatment.

Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma

M. Schmidt, F. V. van Leeuwen, M. Nijziel, 2022, Cancer.

Health care use and remaining needs for support among women with breast cancer in the first 15 months after diagnosis: the role of the GP

N. Aaronson, M. Sprangers, S. Sijtsema, 2019, Family practice.

Adaptive radiotherapy for breast cancer

E. Hahn, D. Zips, D. Thorwarth, 2022, Clinical and translational radiation oncology.

A comparison in cosmetic outcome between per-operative interstitial breast implants and delayed interstitial breast implants after external beam radiotherapy.

A. Hart, J. Peterse, E. Rutgers, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer.

A. Hart, H. Bartelink, A. Begg, 1998, International journal of radiation biology.

A patient decision aid for breast cancer patients deciding on their radiation treatment, no change in decisional conflict but better informed choices

T. van der Weijden, B. Winkens, N. Russell, 2021, Technical innovations & patient support in radiation oncology.

Quantification of patient to patient variation of skin erythema developing as a response to radiotherapy.

A. Hart, J. Lebesque, A. Begg, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Bilateral angiosarcoma of the breast after conservative treatment of bilateral invasive carcinoma: genetic predisposition?

J. Peterse, E. Rutgers, F. van Coevorden, 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

H. Horlings, L. Wessels, T. Schumacher, 2019, Nature Medicine.

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

A. Whittemore, L. Kiemeney, S. Cross, 2016, Nature Communications.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2019, Nature Genetics.

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.

J. Klijn, A. Broeks, L. J. Veer, 2000, American journal of human genetics.

Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations.

A. Hagenbeek, A. Broeks, E. Noordijk, 2000, International journal of radiation biology.

Radiation-induced differentiation of human skin fibroblasts: relationship with cell survival and collagen production.

H. Bartelink, A. Begg, P. Lara, 1996, International journal of radiation biology.

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

H. Horlings, T. Schumacher, L. Wessels, 2019, Nature Medicine.

Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.

J. Dixon, I. Kunkler, L. Williams, 2018, The Lancet. Oncology.

Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.

F. Couch, C. Haiman, A. Cox, 2019, Blood.

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2021, Nature Communications.

Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation.

M. Adank, F. Hogervorst, E. Bleiker, 2022, Critical reviews in oncology/hematology.

FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma.

A. Ashworth, A. Broeks, P. Broderick, 2012, Blood.

Excess Risk for Contralateral Breast Cancer in CHEK2*1100delC Germline Mutation Carriers

J. Klijn, A. Broeks, F. V. van Leeuwen, 2004, Breast Cancer Research and Treatment.

Low-dose ionising radiation and cardiovascular diseases--Strategies for molecular epidemiological studies in Europe.

A. Peters, A. Auvinen, M. Kreuzer, 2015, Mutation research. Reviews in mutation research.

Radiation-associated breast tumors display a distinct gene expression profile.

M. J. van de Vijver, A. Broeks, L. Wessels, 2010, International journal of radiation oncology, biology, physics.

Identification of Differentially Expressed Genes in Mouse Kidney after Irradiation using Microarray Analysis

F. Stewart, L. Boersma, R. Kerkhoven, 2004, Radiation research.

Lack of correlation of human fibroblast radiosensitivity in vitro with early skin reactions in patients undergoing radiotherapy.

J. Lebesque, A. Begg, N. Russell, 1993, International journal of radiation biology.

Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage.

F. Stewart, M. Daemen, J. Kruse, 2006, The American journal of pathology.

Use of fluorescence in situ hybridization to determine the relationship between chromosome aberrations and cell survival in eight human fibroblast strains.

H. Bartelink, A. Begg, C. Arlett, 1995, International journal of radiation biology.

Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol

E. van Werkhoven, P. Elkhuizen, G. Sonke, 2022, Breast Cancer Research and Treatment.

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer

D. Cameron, I. Kunkler, P. Canney, 2017, Breast Cancer Research and Treatment.

Elucidating the role of chest wall irradiation in 'intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trial.

G. Tienhoven, I. Kunkler, P. Canney, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

The influence of adjuvant systemic regimens on contralateral breast cancer risk and receptor subtype.

M. Schmidt, S. Linn, K. K. van de Vijver, 2019, Journal of the National Cancer Institute.

LBA14Adaptive phase II randomized non-comparative trial of nivolumab after induction treatment in triple negative breast cancer: TONIC-trial

H. Horlings, T. Schumacher, S. Linn, 2017 .

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

S Michiels, B Asselain, J Bogaerts, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Microarray analysis to identify molecular mechanisms of radiation-induced microvascular damage in normal tissues.

F. Stewart, L. Boersma, J. Kruse, 2004, International journal of radiation oncology, biology, physics.

Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.

A. Broeks, E. Noordijk, M. Louwman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

H. Horlings, L. Wessels, S. Linn, 2019, Nature Medicine.

Editorial radiotherapy and oncology 2002: predictive assays for normal tissue damage.

A. Begg, N. Russell, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate?

M. J. van de Vijver, J. Yarnold, I. Kunkler, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial

L. Boersma, T. van der Weijden, N. Russell, 2020, Breast Cancer Research and Treatment.

Predictors of enduring clinical distress in women with breast cancer

N. Aaronson, M. Sprangers, A. Reyners, 2016, Breast Cancer Research and Treatment.

Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer

M. Groenvold, M. Sprangers, A. Bottomley, 2019, JNCI cancer spectrum.

Sophisticated radiotherapy with optimal surgery is the way forward

H. Bartelink, N. Russell, 2004, Current opinion in oncology.

Clinical results of image-guided deep inspiration breath hold breast irradiation.

Jan-Jakob Sonke, Anja Betgen, Peter Remeijer, 2010, International journal of radiation oncology, biology, physics.

The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.

E. Rutgers, J. Wesseling, H. Oldenburg, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Treatment strategies in elderly breast cancer patients: Is there a need for surgery?

S. D. de Castro, B. Vrouenraets, N. Russell, 2014, Breast.

The spectrum of ATM missense variants and their contribution to contralateral breast cancer

A. Broeks, M. Schmidt, F. Hogervorst, 2007, Breast Cancer Research and Treatment.

Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy

A. Broeks, M. Wallis, M. Hauptmann, 2017, Clinical and translational radiation oncology.

Explorer The BIG 2 . 04 MRC / EORTC SUPREMO Trial-Pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer

G. Tienhoven, D. Cameron, I. Kunkler, 2017 .

Variability in target volume delineation on CT scans of the breast.

B J Mijnheer, B. Mijnheer, C. Hurkmans, 2001, International journal of radiation oncology, biology, physics.

Thalidomide ameliorates inflammation and vascular injury but aggravates tubular damage in the irradiated mouse kidney.

F. Stewart, R. Coppes, N. Russell, 2014, International journal of radiation oncology, biology, physics.

Understanding radiation-induced cardiovascular damage and strategies for intervention.

F. Stewart, S. Hoving, N. Russell, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Quantification of patient-reported outcome measures of radiation-induced skin reactions for use in clinical trial design

S. Schagen, N. Russell, E. Werkhoven, 2016, Supportive Care in Cancer.

Risk factors of unmet needs among women with breast cancer in the post‐treatment phase

N. Aaronson, M. Sprangers, A. Reyners, 2019, Psycho-oncology.

Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer.

S. Rodenhuis, E. Rutgers, J. Wesseling, 2009, European journal of cancer.

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

H. Horlings, T. Schumacher, L. Wessels, 2019, Nature Medicine.

Prognosis of acute coronary syndromes after radiotherapy for breast cancer.

A. Maas, M. Hooning, C. Seynaeve, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer

S. Darby, M. Hauptmann, M. Hooning, 2018, British Journal of Cancer.

Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors.

D. Rietveld, E. Rutgers, J. Theuws, 2016, International journal of radiation oncology, biology, physics.

In vitro differentiation characteristics of human skin fibroblasts: correlations with radiotherapy-induced breast fibrosis in patients.

A. Hart, H. Bartelink, A. Begg, 2000, International journal of radiation biology.

De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study

L. Boersma, E. Rutgers, J. Maduro, 2023, Breast Cancer Research and Treatment.

Endoglin haploinsufficiency attenuates radiation-induced deterioration of kidney function in mice.

F. Stewart, R. Coppes, N. Russell, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Vascular Damage as an Underlying Mechanism of Cardiac and Cerebral Toxicity in Irradiated Cancer Patients

F. Stewart, S. Hoving, N. Russell, 2010, Radiation research.

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).

H. Wildiers, J. Bogaerts, J. Yarnold, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

S. Rodenhuis, E. Rutgers, S. Linn, 2010, Annals of Surgical Oncology.

Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer

S. Darby, M. Hauptmann, M. Hooning, 2018, British Journal of Cancer.

Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) survey.

A. Kuten, M. Ozsahin, I. Kunkler, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.

R. Tollenaar, M. Schmidt, E. Rutgers, 2019, Annals of surgery.

Development and Internal Validation of an NTCP-model for Acute Coronary Events after Breast Cancer Radiotherapy: First Results of the MEDIRAD BRACE Study (H2020-Euratom-1.4 / 755523)

H. Langendijk, J. Maduro, F. Leeuwen, 2020 .

Model-Based Selection for Proton Therapy in Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences.

J. Maduro, E. Schuit, M. van Vulpen, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG)

A. Wolff, S. Giordano, K. Ruddy, 2023, The oncologist.

Extensive soft tissue resection with autologous tissue closure for locally recurrent breast cancer: lasting local control and acceptable morbidity.

E. Rutgers, J. Wesseling, N. Russell, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.

J. Wesseling, W. Vogel, H. Teertstra, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.